ArticlePathology oncology research : POR2017

EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer.

Sajid A Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.